Evidence map›Paper›PMID 40718237›Full record

ArticleCureus2025

Rapid Eye Movement (REM)-Predominant Central Sleep Apnea With Alpha-Delta Sleep Pattern: A Case Report.

Rafeek Kandy, Lubna Alhourani, Mateen Uzbeck, Said Isse, Ali Wahla, Zaid Zoumot, Adam Bennett, Irfan Shafiq

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rafeek KandyRespiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.
Lubna AlhouraniRespiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.
Mateen UzbeckRespiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.
Said IsseRespiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.
Ali WahlaRespiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.
Zaid ZoumotRespiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.
Adam BennettRespiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.
Irfan ShafiqRespiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Central sleep apnea (CSA) occurring predominantly during rapid eye movement (REM) sleep represents an unusual clinical phenomenon, as CSA typically occurs during non-rapid eye movement (NREM) sleep. We present the case of a 32-year-old male with severe obstructive sleep apnea (OSA), with an apnea-hypopnea index (AHI) of 65.5/hr, who exhibited central apneas mainly during REM sleep (central apnea index: 35.9/hr in REM vs. 5.2/hr in NREM), along with concurrent alpha-delta sleep pattern during slow-wave sleep. The patient was taking tramadol 100 mg and pregabalin 300 mg daily for chronic back pain. Continuous positive airway pressure (CPAP) therapy at 6 cmH₂O effectively managed the OSA and resolved both central apneas and the alpha-delta sleep pattern despite continued medication use. The CPAP therapy reduced the total AHI from 65.5/hr to 1.3/hr, with the central apnea index decreasing from 35.9/hr to 0/hr during REM sleep. This case contributes to the limited literature on REM-predominant CSA and demonstrates the efficacy of standard CPAP therapy in this uncommon presentation, suggesting complex interactions among pharmacological agents, sleep architecture, and respiratory control mechanisms.

Indexed as

alpha-delta sleepcentral sleep apneacpap therapyopioid-induced central apneapregabalinrem-predominant csatramadol

Identifiers

PMID40718237
PMCPMC12290312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.